Further analysis of the effect of the expression status of the signature gene on the prognosis of non-small cell patients by Kaplan-Meier (KM) plotter, compared with the high expression group, the low expression group of RHEBL1 in non-small cell lung cancer patients (including LUAD and LUSC) showed significantly favorable in OS, FP. This evidence concerns the gene RHEBL1 and non-small cell lung carcinoma.